Topical clindamycin treatment of acne. Clinical, surface lipid composition, and quantitative surface microbiology response.
A double-blind study has been conducted to examine the effect of topical 1% clindamycin hydrochloride hydrate in a hydroalcoholic vehicle as compared to the effect of the vehicle alone. Fourteen patients applied clindamycin or vehicle alone twice daily for eight weeks. Free fatty acid surface lipid percentages, quantitative bacterial counts, and clinical response were assessed every two weeks. A significant reduction (88%) in the percentage of free fatty acids in the surface lipids was seen in the clindamycin-treated group and not in the vehicle-treated group. There was no significant change in the surface microflora. Despite the short duration of treatment, objective clinical improvement was seen in three of nine treated patients, while none was observed in the placebo-treated patients.
D000152:Acne Vulgaris / Q000188:drug therapy*; D002981:Clindamycin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005230:Fatty Acids, Nonesterified / Q000032:analysis; D005260:Female; D006801:Humans; D008055:Lipids / Q000032:analysis*; D008297:Male; D011425:Propionibacterium acnes / Q000302:isolation & purification; D012867:Skin / Q000032:analysis* / Q000382:microbiology; D013499:Surface Properties
D005230:Fatty Acids, Nonesterified; D008055:Lipids; D002981:Clindamycin